Peripheral T-Cell Tolerance Defined through Transgenic Mouse Studies

References

• Bevan M. J. In thymic selection, peptide diversity gives and takes away. Immunity 1997; 7: 175–178
   PubMedGoogle Scholar
• Goldrath A. W., Bevan M. J. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 1999b; 11: 183–190
   PubMedGoogle Scholar
• Sprent J., Lo D., Gao E. K., Ron Y. T cell selection in the thymus. Immunol Rev 1988; 101: 173–190
   PubMed Web of Science ®Google Scholar
• Miller J. F., Heath W. R., Allison J., Morahan G., Hoffmann M., Kurts C., Kosaka H. T cell tolerance and autoimmunity. Ciba Found Symp 1997; 204: 159–168
   PubMedGoogle Scholar
• Laufer T. M., DeKoning J., Markowitz J. S., Lo D., Glim-Cher L. H. Unopposed positive selection and autore-activity in mice expressing class II MHC only on thymic cortex. Nature 1996; 383: 81–85
   PubMedGoogle Scholar
• Brocker T., Riedinger M., Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class 11 molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541–550
   PubMed Web of Science ®Google Scholar
• Rellahan B. L., Jones L. A., Kruisbeek A. M., Fry A. M., Matis L. A. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med 1990; 172: 1091–1100
   PubMed Web of Science ®Google Scholar
• White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Sundstedt A., Hoiden I., Hansson J., Hedlund G., Kalland T., Dohlsten M. Superantigen-induced anergy in cytotoxic CD8+ T cells. J. Immunol 1995; 154: 6306–6313
   PubMed Web of Science ®Google Scholar
• Nakagawa K., Harrison L. C. The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996; 152: 193–236
   PubMed Web of Science ®Google Scholar
• Miller J. F., Basten A. Mechanisms of tolerance to self. Curr Opin Immunol 1996; 8: 815–821
   PubMed Web of Science ®Google Scholar
• Burns J., Rosenzweig A., Zweiman B., Moskovitz A., Lisak R. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis. J Immunol 1984; 132: 2690–2692
   PubMedGoogle Scholar
• Yan T., Burkhardt H., Ritter T., Broker B., Mann K. H., Bertling W. M., von der Mark K., Emmrich F. Specificity and T cell receptor beta chain usage of a human collagen type Il-reactive T cell clone derived from a healthy individual. Eur J Immunol 1992; 22: 51–56
   PubMed Web of Science ®Google Scholar
• Liu G. Y., Fairchild P. J., Smith R. M., Prowle J. R., Kioussis D., Wraith D. C. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 1995; 3: 407–415
   PubMed Web of Science ®Google Scholar
• Doan T., Herd K., Street M., Bryson G., Fernando G., Lambert P., Tindle R. Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles. J Virol 1999; 73: 6166–6170
   PubMedGoogle Scholar
• Heath W. R., Karamalis F., Donoghue J., Miller J. F. Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity. J Immunol 1995; 155: 2339–2349
   PubMedGoogle Scholar
• Ohashi P. S., Oehen S., Aichele P., Pircher H., Odermait B., Herrera P., Higuchi Y., Buerki K., Hengartner H., Zinkernagel R. M. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J Immunol 1993; 150: 5185–5194
   PubMed Web of Science ®Google Scholar
• Wei C., Willis R. A., Tilton B. R., Looncy R. J., Lord E. M., Barth R. K., Frelinger J. G. Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy. Proc Natl Acad Set USA 1997; 94: 6369–6374
   PubMed Web of Science ®Google Scholar
• Morgan D. J., Kreuwel H. T., Sherman L. A. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 1999; 163: 723–727
   PubMed Web of Science ®Google Scholar
• Sheng B., Odebralski J. M., Smith R. T. All or none peripheral tolerance induction in H-Y antigen-specific TCR transgenic mice. Transpl Immunol 1998; 6: 78–83
   PubMedGoogle Scholar
• Schonrich G., Momburg F., Malissen M., Schmitt Verhulst A. M., Malissen B., Hammerling G. J., Arnold B. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 1992; 4: 581–590
   PubMedGoogle Scholar
• Ferber I., Schonrich G., Schenkel J., Mellor A. L., Hammerling G. J., Arnold B. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 1994; 263: 674–676
   PubMed Web of Science ®Google Scholar
• Shevach E. M., Thornton A., Suri Payer E. T lymphocyte-mediated control of autoimmunity. Novartis Found Symp 1998; 215: 200–211
   PubMedGoogle Scholar
• Cohen P. L., Eisenberg R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphoprolifera-tive disease. Annu Rev Immunol 1991; 9: 243–269
   PubMed Web of Science ®Google Scholar
• Dai Z., Arakelov A., Wagener M., Konieczny B. T., Lak-Kis F. G. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death. J Immunol 1999; 163: 3131–3137
   PubMedGoogle Scholar
• Lamy T., Liu J. H., Landowski T. H., Dalton W. S., Loughran T. P., Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92: 4771–1777
   PubMed Web of Science ®Google Scholar
• Bertolino P., Heath W. R., Hardy C. L., Morahan G., Miller J. F. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol 1995; 25: 1932–1942
   PubMed Web of Science ®Google Scholar
• Marth T., Zeitz M., Ludviksson B. R., Strober W., Kelsall B. L. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J Immunol. 1999; 162: 7233–7240
   PubMedGoogle Scholar
• Butcher E. C., Picker L. J. Lymphocyte homing and homeostasis. Science 1996; 272: 60–66
   PubMed Web of Science ®Google Scholar
• Mackay C. R., Marston W. L., Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 1990; 171: 801–817
   PubMed Web of Science ®Google Scholar
• Sallusto F., Lenig D., Forster R., Lipp M., Lanzavec-Chia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708–712
   PubMed Web of Science ®Google Scholar
• Kurts C., Heath W. R., Carbone F. R., Allison J., Miller J. F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184: 923–930
   PubMed Web of Science ®Google Scholar
• Kurts C, Carbone F. R., Barnden M., Blanas E., Allison J., Heath W. R., Miller J. F. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997; 186: 2057–2062
   PubMed Web of Science ®Google Scholar
• Lo D., Freedman J., Hesse S., Palmiter R. D., Brinster R. L., Sherman L. A. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol 1992; 22: 1013–1022
   PubMed Web of Science ®Google Scholar
• Schmidt C. M., Garrett E., Orr H. T. Cytotoxic T lymphocyte recognition of HLA-G in mice. Hum Immunol 1997; 55: 127–139
   PubMed Web of Science ®Google Scholar
• Adler A. J., Marsh D. W., Yochum G. S., Guzzo J. L., Nigam A., Nelson W. G., Pardoll D. M. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 1998; 187: 1555–1564
   PubMed Web of Science ®Google Scholar
• Antoniou A., McCormick D., Scott D., Yeoman H., Chandler P., Mellor A., Dyson J. T cell tolerance and activation to a transgene-encoded tumor antigen. Eur J Immunol 1996; 26: 1094–1102
   PubMedGoogle Scholar
• DoanChambers T. M., Street M., Fernando G. J., Herd K., Lambert P., Tindle R. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology 1998; 244: 352–364
   PubMedGoogle Scholar
• Kurts C., Miller J. F., Subramaniam R. M., Carbone F. R., Heath W. R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998; 188: 409–414
   PubMed Web of Science ®Google Scholar
• Bennett S. R., Carbone F. R., Toy T., Miller J. F., Heath W. R. B cells directly tolerize CD8(+) T cells. J Exp Med 1998; 188: 1977–1983
   PubMed Web of Science ®Google Scholar
• Vella A T, Scherer M. T., Schultz L., Kappler J. W., Mar-Rack P. B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci USA 1996; 93: 951–955
   PubMedGoogle Scholar
• Finkelman F. D., Lees A., Birnbaum R., Cause W. C., Morris S. C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996; 157: 1406–1414
   PubMed Web of Science ®Google Scholar
• Frasca L., Piazza C., Piccolella E. CD4+ T cells orchestrate both amplification and deletion of CD8+ T cells. Crit Rev Immunol 1998; 18: 569–594
   PubMed Web of Science ®Google Scholar
• Schoenberger S. P., Toes R. E., van der Voort E. I., Offringa R., Melief C. J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions [see comments). Nature 1998; 393: 480–483
   PubMed Web of Science ®Google Scholar
• Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183: 1789–1796
   PubMed Web of Science ®Google Scholar
• Mueller D. L., Jenkins M. K., Schwartz R. H. Clonal expansion versus functional clonal inactivation: a cos-timulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445–480
   PubMed Web of Science ®Google Scholar
• Kang S. M., Beverly B., Tran A. C., Brorson K., Schwartz R. H., Lenardo M. J. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 1992; 257: 1134–1138
   PubMed Web of Science ®Google Scholar
• Gajewski T. F., Lancki D. W., Stack R., Fitch F. W. “Anergy” of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition lo a TH2-like phenotype. J Exp Med 1994; 179: 481–491
   PubMedGoogle Scholar
• SloanLancaster J., Evavold B. D., Allen P. M. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med. 1994; 180: 1195–1205
   PubMedGoogle Scholar
• Bal V., McIndoe A., Denton G., Hudson D., Lombardi G., Lamb J., Lechler R. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990; 20: 1893–1897
   PubMed Web of Science ®Google Scholar
• Guerder S., Meyerhoff J., Flavell R. The role of the T cell costimulator B7–1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1994; 1: 155–166
   PubMed Web of Science ®Google Scholar
• Bluestone J. A. Is CTLA-4 a master switch for peripheral T cell tolerance. J Immunol 1997; 158.: 1989–1993
   PubMed Web of Science ®Google Scholar
• Luhder F., Hoglund P., Allison J. P., Benoist C., Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 1998; 187: 427–432
   PubMed Web of Science ®Google Scholar
• Rocha B., Tanchot C., Von Boehmer H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp Med. 1993; 177: 1517–1521
   PubMed Web of Science ®Google Scholar
• Ryan K. R., Evavold B. D. Persistence of pep-tide-induced CD4+ T cell anergy in vitro. J Exp Med 1998; 187: 89–96
   PubMedGoogle Scholar
• Dillon S. R., MacKay V. L., Fink P. J. A functionally compromised -intermediate in extrathymic CD8+ T cell deletion. Immunity 1995; 3: 321–333
   PubMedGoogle Scholar
• Fink P. J., Fang C. A., Turk G. L. The induction of peripheral tolerance by the chronic activation and deletion of C.D4+V beta 5+ cells'. Immunol 1994; 152: 4270–4281
   Google Scholar
• Moskophidis D., Lechner F., Pircher H., Zinkernagel R. M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells [published erratum appears in Nature 1993 Jul 15; 364(6434): 262] [sec comments|. Nature 1993; 362: 758–761
   PubMed Web of Science ®Google Scholar
• Moskophidis D., Laine E., Zinkernagel R. M. Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur J Immunol 1993; 23: 3306–3311
   PubMedGoogle Scholar
• Kyburz D., Speiser D. E., Battegay M., Hengartner H., Zinkernagel R. M. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Eur J Immunol 1993; 23: 1540–1545
   PubMedGoogle Scholar
• Chen Y., Inobe J., Weiner H. L. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell Immunol 1997; 178: 62–68
   PubMedGoogle Scholar
• Mueller D. L., Jenkins M. K. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr Opin Immunol 1995; 7: 375–381
   PubMed Web of Science ®Google Scholar
• Heath W. R., Allison J., Hoffmann M. W., Schonrich G., Hammcrling G., Arnold B., Miller J. F. Autoimmune diabetes as a consequence of locally produced inter-leukin-2. Nature 1992; 359: 547–549
   PubMed Web of Science ®Google Scholar
• Liblau R. S., Singer S. M., McDevitt H. O. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases [see comments]. Immunol Today 1995; 16: 34–38
   PubMedGoogle Scholar
• Kumar V., Sercarz E. E. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J Exp Med 1993; 178: 909–916
   PubMed Web of Science ®Google Scholar
• Hamano K., Rawsthorne M. A., Bushell A. R., Morris P. J., Wood K. J. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 1996; 62: 856–860
   PubMed Web of Science ®Google Scholar
• Armstrong H. E., Bolton E. M., McMillan I., Spencer S. C., Bradley J. A. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC ntigens. J Exp Med 1987; 165: 891–907
   PubMedGoogle Scholar
• Ferraresso M., Tian L., Ghobrial R., Stepkowski S. M., Kahan B. D. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. J Immunol 1994; 153: 3307–3318
   PubMedGoogle Scholar
• Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. “Infectious” transplantation tolerance. Science 1993; 259.: 974–977
   PubMed Web of Science ®Google Scholar
• Field E. H., Gao Q., Chen N. X., Rouse T. M. Balancing the immune system for tolerance; a case for regulatory CD4 cells. Transplantation 1997; 64: 1–7
   PubMedGoogle Scholar
• Chang C. H., Fume M., Tamaki K. B7–1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by inlerferon-gamma or by interleukin-10. Eur J Immunol 1995; 25: 394–398
   PubMed Web of Science ®Google Scholar
• Vossen A. C., Tibbe G. J., Benner R., Savelkoul H. F. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice. Transplant Proc 1995; 27: 380–382
   PubMedGoogle Scholar
• Chan S. Y., DeBruyne L. A., Goodman R. E., Eichwald E. J., Bishop D. K. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155–1161
   PubMed Web of Science ®Google Scholar
• Cobbold S. P., Adams E., Marshall S. E., Davies J. D., Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CDS. Immunol Rev 1996; 149: 5–33
   PubMed Web of Science ®Google Scholar
• Miller J. F., Flavell R. A. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr Opin Immunol 1994; 6: 892–899
   PubMed Web of Science ®Google Scholar
• Modigliani Y., Coutinho A., Pereira P., Le Douarin N., ThomasVaslin V., Burlen Defranoux O., Salaun J., Ban-Deira A. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol 1996; 26: 1807–1815
   PubMed Web of Science ®Google Scholar
• Teng Y. T., Williams D. B., Hozumi N., Gorczynski R. M. Multiple levels of regulation for self-tolerance in beef insulin transgenic mice. Cell Immunol 1996; 173: 183–191
   PubMedGoogle Scholar
• Wang Y., Goldschneider I., Foss D., Wu D. Y., O'Rourke J., Cone R. E. Direct thymic involvement in anterior chamber-associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adult mice. J Immunol 1997; 158: 2150–2155
   PubMedGoogle Scholar
• Blish C. A., Gallay B. J., Turk G. L., Kline K. M., Wheat W., Fink P. J. Chronic modulation of the TCR repertoire in the lymphoid periphery. J Immunol 1999; 162: 3131–3140
   PubMed Web of Science ®Google Scholar
• Zheng B., Han S., Zhu Q., Goldsby R., Kelsoe G. Alternative pathways for the selection of antigen-specific peripheral T cells. Nature 1996; 384: 263–266
   PubMedGoogle Scholar
• Tanchot C., Lemonnier F. A., Perarnau B., Freitas A. A., Rocha B. Differential requirements for survival and proliferation of CDS naive or memory T cells [see comments). Science 1997; 276: 2057–2062
   PubMed Web of Science ®Google Scholar
• Murali-Khrishna K., Lau L. L., Sambhara S., Lemonnier F., Altman J., Ahmed R. Persistence of memory CDS T cells in MHC Class-1 deficient mice. Science 1999; 286: 1377–1381
   PubMedGoogle Scholar
• Goldrath A. W., Bevan M. J. Selecting and maintaining a diverse T-cell repertoire. Nature 1999a; 402: 255–262
   PubMedGoogle Scholar
• Limmer A., Sacher T., Alferink J., Nichterlein T., Arnold B., Hammerling G. J. A two-step model for the induction of organ-specific autoimmunity. Novartis Found Symp 1998; 215: 159–167
   PubMedGoogle Scholar
• Ehl S., Hombach J., Aichele P., Rulicke T., Odermatt B., Hengartner H., Zinkernagel R., Pircher H. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathol-ogy. J Exp Med 1998; 187: 763–774
   PubMed Web of Science ®Google Scholar
• von Herrath M. G., Guerdcr S., Lewicki H., Flavell R. A., Oldstone M. B. Coexprcssion of B7–1 and viral (self) transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995; 3: 727–738
   PubMed Web of Science ®Google Scholar
• Heath W. R., Miller J. F. Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J Exp Med 1993; 178: 1807–1811
   PubMed Web of Science ®Google Scholar
• Kouskoff V., Korganow A. S., Duchatelle V., Benoist C., Degott C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996; 87: 811–822
   PubMed Web of Science ®Google Scholar
• Toes R. E., van der Voort E. I., Schoenberger S. P., Drijfhoul J. W., van Bloois L., Storm G., Kast W. M., Offringa R., Melief C. J. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol 1998; 160.: 4449–4456
   PubMed Web of Science ®Google Scholar
• Soiffer R., Lynch T., Mihm M., Jung K., Rhuda C., Schmollinger J. C., Hodi F. S., et al. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA 1998; 95: 13141–13146
   PubMed Web of Science ®Google Scholar
• Schuler G., Thurner B., Romani N. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int Arch Allergy Immunol 1997; 112: 317–322
   PubMedGoogle Scholar
• Livingston B. D., Alexander J., Crimi C., Oseroff C., Celis E., Daly K., Guidotti L. G., Chisari F. V., Fikes J., Chesnul R. W., Sette A. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol 1999; 162: 3088–3095
   PubMed Web of Science ®Google Scholar
• Carbone F. R., Kurts C., Bennett S. R., Miller J. F., Heath W. R. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 1998; 19: 368–373
   PubMedGoogle Scholar
• von Herrath M. G., Evans C. F., Horwitz M. S., Oldstone M. B. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol Rev 1996; 152: 111–143
   PubMedGoogle Scholar
• Bertolino P., Trescol Biemont M. C., Thomas J., de St Groth B. F., Pihlgren M., Marvel J., Rabourdin Combe C. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 1999; 11: 1225–1238
   PubMed Web of Science ®Google Scholar
• Schonrich G., Kalinke U., Momburg F., Malissen M., Sch-mitt Verhulst A. M., Malissen B., Hammerling G. J., Arnold B. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65.: 293–304
   PubMed Web of Science ®Google Scholar
• Kurts C., Kosaka H., Carbone F. R., Miller J. F., Heath W. R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997; 186: 239–245
   PubMed Web of Science ®Google Scholar
• Hammerling G. J., Schonrich G., Momburg F., Auphan N., Malissen M., Malissen B., Schmitt Verhulst A. M., Arnold B. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class 1 antigen. Immunol Rev. 1991; 122: 47–67
   PubMedGoogle Scholar